PFEIFFER GARY M
SEC CIK 1127304 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| DGX | Quest Diagnostics | Dir | 31.0K | — | $270.3K | 6 | 2022-05-18 | 2026-05-20 |
Most active insiders at DGX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Davis J. E. | CEO, Pres, Dir | — | $17.08M |
| 2 | Doherty Catherine T. | EVP, Regional Businesses | — | $6.96M |
| 3 | PREVOZNIK MICHAEL E | SVP, GC | — | $6.69M |
| 4 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | — | $2.17M |
| 5 | Plewman Patrick | SVP for Diagnostic Services | — | $2.03M |
| 6 | DELANEY MARK E | SVP, Chief Commercial Off | — | $1.86M |
| 7 | PFEIFFER GARY M | Dir | — | $270.3K |
| 8 | Gregg Vicky B | Dir | — | $239.7K |
| 9 | Lassiter Wright III | Dir | — | — |
| 10 | Deppe Michael J | SVP, CAO, Corp. Ctrl | — | — |
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-21 16:52 | 2026-05-20 | DGX | Quest Diagnostics | PFEIFFER GARY M | Dir | A - Grant | $0.00 | +1,142 | 31.0K | +4% | $0 | |
| D | 2025-10-24 | 2025-10-22 | DGX | Quest Diagnostics | PFEIFFER GARY M | Dir | S - Sale | $182.40 | -1,482 | 29.4K | -5% | -$270.3K |
| 2025-05-19 | 2025-05-15 | DGX | Quest Diagnostics | PFEIFFER GARY M | Dir | A - Grant | $0.00 | +1,203 | 30.7K | +4% | $0 | |
| 2024-05-20 | 2024-05-16 | DGX | Quest Diagnostics | PFEIFFER GARY M | Dir | A - Grant | $0.00 | +1,482 | 28.9K | +5% | $0 | |
| 2023-05-19 | 2023-05-17 | DGX | Quest Diagnostics | PFEIFFER GARY M | Dir | A - Grant | $0.00 | +1,369 | 26.8K | +5% | $0 | |
| 2022-05-20 | 2022-05-18 | DGX | Quest Diagnostics | PFEIFFER GARY M | Dir | A - Grant | $0.00 | +1,292 | 25.0K | +5% | $0 |
Purchase Sale Sale after option exercise All abbreviations